Besigomsin

DB20894ExperimentalSmall molecule

Besigomsin is a small molecule drug. Besigomsin has a monoisotopic molecular weight of 416.18 Da.

Mechanism: Pharmacologically active on Acetylcholinesterase and Transient receptor potential cation channel subfamily V member 1
Curator reviewed
Formula / weight: C₂₃H₂₈O₇ · 416.47 g/mol (avg)
Code names: TJN-101

Resolves to

Compound

Structure

InChIKeyZWRRJEICIPUPHZ-MYODQAERSA-NSMILESCOC1=CC2=C(C(OC)=C1OC)C1=C(C[C@H](C)[C@@](C)(O)C2)C=C2OCOC2=C1OC

Targets

Transporters

What you can answer from here — as of August 31, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2TransportersSubstrate / inhibitor direction, not just membership

Listed above

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Besigomsin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.